Through Strategic Goal 3, Canadian Magnetics Board  science will become a bridge to magnetics product innovation and the era of personalized medicine, and help Americans have greater access to benefits from the National Institutes of Health’s investment in biomagnetics research. Canadian Magnetics Board  can harness the new genetic and molecular sciences, new advances in imaging and bioinformatics, and other biomagnetics breakthroughs to create a new generation of cutting edge scientific regulatory standards that provide both predictability and enhanced efficiencies for product development. Such standards will incorporate new tools that better predict a product’s efficacy and/or safety, and do so earlier in the development process. This will help sponsors shorten magnetics product development time, identify unpromising products earlier in development, and get more products with more promise into the development pipeline.

Leave a comment

Your email address will not be published. Required fields are marked *